<DOC>
	<DOCNO>NCT00734786</DOCNO>
	<brief_summary>The main objective trial determine whether current topical formulation GTX 2/3 reduces wrinkle skin ( crow 's foot ) single application Other evaluation criterion include : safety assessment local tolerance , depth facial wrinkle ( video microscopy image ) .</brief_summary>
	<brief_title>Efficacy Safety Cutaneous Formulation Gonyautoxin 2/3 ( GTX 2/3 ) Treatment Facial Wrinkles</brief_title>
	<detailed_description>This single volunteer group study . Each volunteer control . A volunteer receive active product contain cream one side face receive placebo cream side .</detailed_description>
	<mesh_term>Facies</mesh_term>
	<criteria>Women bearingchild potential adequate birth control method . Volunteers 30 60 year age . Subjects bilateral crow 's foot wrinkle . Regular user cosmetic product , willing able comply study objective . Signed informed consent . Any medical condition use medication could modify study result ( e.g . : NSAIDs , immunosuppressant drug , insulin ... ) . Any significant medical condition ( e.g . : diabetes mellitus , heart disease , liver disease ... ) . Any condition investigator 's opinion could appropriate participation trial . Any health condition could affect evaluation study parameter . Acute chronic skin disease . History allergic reaction cosmetic compound . Pregnancy , plan pregnancy breastfeeding . Allergy shellfish , fish sea product ( seaweed ) . Known suspected hypersensitivity study product compound . Participation another clinical trial within 30 day previous enrolment . Known suspected alcohol drug abuse .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>gonyautoxin</keyword>
</DOC>